Cognitive Effects of Nimodipine in Patients With Schizophrenia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

May 12, 2023

Study Completion Date

May 12, 2023

Conditions
SchizophreniaSchizo Affective Disorder
Interventions
DRUG

Nimodipine

Subject will receive two 30mg capsules of nimodipine during study visit.

DRUG

Placebo oral capsule

Two coconut oil capsules that mimic the size and color of the nimodipine capsules

Trial Locations (2)

21224

Johns Hopkins Bayview Medical Center, Baltimore

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03671525 - Cognitive Effects of Nimodipine in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter